Pulmonx, a medical device co., raises $18.5M
Pulmonx, a Palo Alto, Calif. developer of medical devices for interventional pulmonology, has secured commitments of about $18.5 million for a $20.5 million second round, according to a regulatory filing cited by PE Week. MedVenture Associates was joined by existing investors, including Montreux Equity Partners.
Next Story: ChemoCentryx, autoimmune disease drug co., raises $29.84M
Previous Story: ScanR, a cross-device scanner company, raises $8M more
VB Writers
Ben PopperEast Coast Editor
Dean TakahashiLead Writer, GamesBeat
Devindra HardawarNational Editor, MobileBeat Lead
Dylan TweneyExecutive Editor
ShoeEditor-in-Chief, GamesBeat
Heather KellySenior Editor
Jennifer Van GroveWriter
Jolie O'DellWriter
Matt MarshallFounder & Editor-in-Chief
Meghan KellyWriter
Sarah MitroffEditorial Assistant
Sean LudwigWriter
Sebastian HaleyReviews Editor, GamesBeat
Tom CheredarWriter
Ciara ByrneContributor
Julia PlevinContributor
Lindsey ComptonContributor
